Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Brain Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2827851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist.

  1987cited by this paper
• Biochemical and functional interactions of a selective kappa opioid agonist with calcium.

  1987cited by this paper
• A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia.

  1986cited by this paper
• Suloctidil treatment prevents the development of post-traumatic feline spinal cord ischemia.

  1985cited by this paper
• Ischaemic brain damage: the role of excitatory activity and of calcium entry.

  1985cited by this paper
• [3H]U-69593 a highly selective ligand for the opioid kappa receptor.

  1985cited by this paper
• High-dose glucocorticoid treatment improves neurological recovery in head-injured mice.

  1985cited by this paper
• Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent.

  1985cited by this paper
• Beneficial Effects of Acute Intravenous Ibuprofen on Neurologic Recovery of Head-Injured Mice: Comparison of Cyclooxygenase Inhibition with Inhibition of Thromboxane A2 Synthetase or 5-Lipoxygenase

  1985cited by this paper
• Dynorphin(1–13) improves survival in cats with focal cerebral ischaemia

  1984cited by this paper
• U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

  1983cited by this paper
• Dynorphin induces partially reversible paraplegia in the rat.

  1983cited by this paper
• Experimental spinal cord injury: treatment with naloxone.

  1982cited by this paper
• Endorphins in experimental spinal injury: Therapeutic effect of naloxone

  1981cited by this paper
• Effect of naloxone on posttraumatic ischemia in experimental spinal contusion.

  1981cited by this paper

• GPCRs in traumatic brain or spinal injury.

  2025cites this paper
• Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder

  2021cites this paper
• Opioids and opioid receptors orchestrate wound repair.

  2017cites this paper
• Kappa Opioid Receptor Agonist and Brain Ischemia.

  2014cites this paper
• Using anesthetics and analgesics in experimental traumatic brain injury

  2013cites this paper
• Time-harmonic magnetic resonance elastography of the normal feline brain.

  2010cites this paper
• Opiates and the development of post-injury complications: a review.

  2008cites this paper
• The role of mutagenesis in defining genes in behaviour

  2006cites this paper
• Morphine protects for head trauma induced cognitive deficits in mice.

  2006cites this paper
• Instrumental learning within the spinal cord: underlying mechanisms and implications for recovery after injury.

  2006cites this paper
• Role of the opioid system in the behavioral deficit observed after uncontrollable shock

  2006cites this paper
• Timing of Surgery Following Spinal Cord Injury

  2005cites this paper
• Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599

  2005cites this paper
• Quantitative Analysis of Effects of K-Opioid Agonists on Postischemic Hippocampal Neuronal Necrosis in Gerbils

  2005cites this paper
• Pathobiology of dynorphins in trauma and disease.

  2005cites this paper
• The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons.

  2005cites this paper
• Ischemic reperfusion brain injury in fetal transgenic mice with elevated levels of copper-zinc superoxide dismutase

  2002cites this paper
• Acute Spinal Cord Injury, Part II: Contemporary Pharmacotherapy

  2001cites this paper
• Role of Nociceptin/Orphanin FQ in Age-Dependent Cerebral Hemodynamic Effects of Brain Injury

  2000cites this paper
• Niravoline, a selective kappa-opioid receptor agonist effectively reduces elevated intracranial pressure

  2000cites this paper
• Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes.

  2000cites this paper
• Age‐Dependent Cerebral Hemodynamic Effects of Traumatic Brain Injury in Newborn and Juvenile Pigs

  2000cites this paper
• Opioid peptide receptor studies. 10. Nor‐BNI differentially inhibits kappa receptor agonist‐induced G‐protein activation in the guinea pig caudate: Further evidence of kappa receptor heterogeneity

  1999cites this paper
• Current concepts in the management of acute spinal cord injury.

  1999cites this paper
• Regeneration of the lesioned spinal cord

  1998cites this paper
• Cerebral hemodynamics after traumatic brain injury of immature brain.

  1998cites this paper
• Altered release of prostaglandins by opioids contributes to impaired cerebral hemodynamics following brain injury.

  1998cites this paper
• Head injury therapies.

  1997cites this paper
• Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase.

  1997cites this paper
• Effects of Nalmefene, CG3703, Tirilazad, or Dopamine on Cerebral Blood Flow, Oxygen Delivery, and Electroencephalographic Activity After Traumatic Brain Injury and Hemorrhage

  1997cites this paper
• Role of Opioids in the Physiologic and Pathophysiologic Control of the Cerebral Circulation 1

  1997cites this paper
• Novel developments with selective, non-peptidic kappa-opioid receptor agonists.

  1997cites this paper
• Endothelin production links superoxide generation to altered opioid-induced pial artery vasodilation after brain injury in pigs.

  1997cites this paper
• Reduction of the Neurological Deficit in Mice with Traumatic Brain Injury by Nitric Oxide Synthase Inhibitors

  1996cites this paper
• Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms.

  1996cites this paper
• Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.

  1996cites this paper
• Role of Vasopressin in Altered Pial Artery Responses to Dynorphin and β-Endorphin following Brain Injury

  1996cites this paper
• Influence of Polyethylene Glycol Superoxide Dismutase/Catalase on Altered Opioid‐induced Pial Artery Dilation after Brain Injury

  1996cites this paper
• Pharmacological treatment of central nervous system trauma.

  1996cites this paper
• Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

  1995cites this paper
• Relationship between opioids and activation of phospholipase C and protein kinase C in brain injury induced pial artery vasoconstriction.

  1995cites this paper
• U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia.

  1994cites this paper
• Brain protection.

  1994cites this paper
• The Effects of Naloxone on Retinal Ischemia in Rats

  1994cites this paper
• The role of opioids in newborn pig fluid percussion brain injury.

  1994cites this paper
• Neurochemical sequelae of traumatic brain injury: therapeutic implications.

  1994cites this paper
• Kappa opioids: therapeutic considerations in epilepsy and CNS injury.

  1994cites this paper
• Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site.

  1993cites this paper
• Molecular mechanisms of trauma-induced neuronal degeneration.

  1993cites this paper
• Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice.

  1993cites this paper
• Comparison of Single and Combination Drug Treatment Strategies in Experimental Brain Trauma

  1993cites this paper
• Novel Pharmacologic Therapies in the Treatment of Experimental Traumatic Brain Injury: A Review

  1993cites this paper
• Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat.

  1993cites this paper
• Neuroprotective Effect of the χ‐Agonist Enadoline (CI‐977) in Rat Models of Focal Cerebral Ischaemia

  1993cites this paper
• Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury.

  1993cites this paper
• Activation of kappa-opioid receptors in the nucleus ambiguus does not affect cardiovascular function or outcome following acute hemorrhage in the rat.

  1993cites this paper
• A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat.

  1993cites this paper
• Pharmacologic strategies in the treatment of experimental brain injury.

  1992cites this paper
• Cholinergic and opioid mediation of traumatic brain injury.

  1992cites this paper
• Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences.

  1992cites this paper
• Chemical structures and biological activities of non-peptide selective kappa opioid ligands.

  1992cites this paper
• Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique.

  1992cites this paper
• Pharmacological strategies in CNS trauma.

  1992cites this paper
• Role of oxygen-derived free radicals in the pathogenesis of shock and trauma, with focus on central nervous system injuries.

  1992cites this paper
• Pharmacologic strategies in the treatment of experimental spinal cord injury.

  1992cites this paper
• Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil.

  1991cites this paper
• Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.

  1991cites this paper
• Synthesis and in vitro characterization of fluorinated U-50488 analogs for PET studies of kappa opioid receptors.

  1990cites this paper
• Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury

  1990cites this paper
• N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography.

  1990cites this paper
• Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.

  1989cites this paper
• Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury.

  1989cites this paper
• Pharmacological activities of optically pure enantiomers of the κ opioid agonist, U50,488, and its cis diastereomer: evidence for three κ receptor subtypes

  1989cites this paper
• Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils.

  1988cites this paper